Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yakup Iriagac

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|November 15, 2022
Comprehensive Analysis of Prognostic Factors in Advanced Gastric Cancer Patients Treated with ChemotherapyEyyup Cavdar, Yakup Iriagac, Okan Avci, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|October 8, 2025
Predictive Factors for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing <sup>177</sup>Lu-PSMA-617 Radioligand TreatmentSeray Saray, Hasan Bozkurt, Eyyup Cavdar, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|May 16, 2023
A New Mortality Prediction Model in Advanced Stage Cancer Patients Requiring Hospitalisation while Receiving Active Systemic TherapyKubilay Karaboyun, Yakup Iriagac, Eyyup Cavdar, et al.
Journal of Geriatric Oncology|April 1, 2022
Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancerEyyup Cavdar, Yakup Iriagac, Kubilay Karaboyun, et al.
Revista Da Associacao Medica Brasileira (1992)|October 22, 2025
Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?Yakup İriagac, Meltem Oznur, Eyyup Çavdar, et al.
Revista Da Associacao Medica Brasileira (1992)|March 15, 2023
A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapyErdoğan Selçuk Şeber, Yakup İriagac, Eyyup Çavdar, et al.
Bratislavske Lekarske Listy|May 16, 2022
Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancerYakup Iriagac, Eyyup Cavdar, Kubilay Karaboyun, et al.
Medicina (Kaunas, Lithuania)|May 25, 2024
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective ExperienceNebi Serkan Demirci, Eyyup Cavdar, Nuriye Yildirim Ozdemir, et al.
Journal of Cancer Research and Therapeutics|June 14, 2023
Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinibYakup Iriagac, Eyyup Cavdar, Kubilay Karaboyun, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|January 8, 2024
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast CancerErdogan Selcuk Seber, Yakup Iriagac, Eyyup Cavdar, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|November 15, 2022
Comprehensive Analysis of Prognostic Factors in Advanced Gastric Cancer Patients Treated with ChemotherapyEyyup Cavdar, Yakup Iriagac, Okan Avci, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|October 8, 2025
Predictive Factors for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing <sup>177</sup>Lu-PSMA-617 Radioligand TreatmentSeray Saray, Hasan Bozkurt, Eyyup Cavdar, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|May 16, 2023
A New Mortality Prediction Model in Advanced Stage Cancer Patients Requiring Hospitalisation while Receiving Active Systemic TherapyKubilay Karaboyun, Yakup Iriagac, Eyyup Cavdar, et al.
Journal of Geriatric Oncology|April 1, 2022
Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancerEyyup Cavdar, Yakup Iriagac, Kubilay Karaboyun, et al.
Revista Da Associacao Medica Brasileira (1992)|October 22, 2025
Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?Yakup İriagac, Meltem Oznur, Eyyup Çavdar, et al.
Revista Da Associacao Medica Brasileira (1992)|March 15, 2023
A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapyErdoğan Selçuk Şeber, Yakup İriagac, Eyyup Çavdar, et al.
Bratislavske Lekarske Listy|May 16, 2022
Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancerYakup Iriagac, Eyyup Cavdar, Kubilay Karaboyun, et al.
Medicina (Kaunas, Lithuania)|May 25, 2024
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective ExperienceNebi Serkan Demirci, Eyyup Cavdar, Nuriye Yildirim Ozdemir, et al.
Journal of Cancer Research and Therapeutics|June 14, 2023
Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinibYakup Iriagac, Eyyup Cavdar, Kubilay Karaboyun, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|January 8, 2024
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast CancerErdogan Selcuk Seber, Yakup Iriagac, Eyyup Cavdar, et al.
Pageof 2